Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NYBORG DYREHOSPITAL - gamle firma ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.8% 3.3% 5.3% 4.7% 6.7% 6.5% 13.5% 13.5%   Credit score (0-100)   52 56 42 44 35 35 17 17   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,123 3,435 6,687 -21.2 -5.2 -19.5 0.0 0.0   EBITDA   549 488 4,161 -37.1 -5.2 -19.5 0.0 0.0   EBIT   439 364 4,043 -37.1 -5.2 -19.5 0.0 0.0   Pre-tax profit (PTP)   460.3 389.1 4,054.0 3,267.3 -5.2 -19.5 0.0 0.0   Net earnings   359.0 303.3 3,162.1 2,796.9 -4.0 -15.2 0.0 0.0   Pre-tax profit without non-rec. items   460 389 4,054 3,267 -5.2 -19.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   261 340 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   484 428 3,287 2,922 1,013 998 873 873   Interest-bearing liabilities   2.2 21.7 13.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,631 1,352 5,421 2,948 1,013 1,005 873 873   Net Debt   -557 -392 -1,220 -1,025 -1,005 -1,000 -873 -873     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,123 3,435 6,687 -21.2 -5.2 -19.5 0.0 0.0   Gross profit growth   13.0% 10.0% 94.7% 0.0% 75.4% -273.4% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,631 1,352 5,421 2,948 1,013 1,005 873 873   Balance sheet change%   18.1% -17.2% 301.1% -45.6% -65.6% -0.8% -13.2% 0.0%   Added value   549.5 488.2 4,161.2 -37.1 -5.2 -19.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -166 -46 -458 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.1% 10.6% 60.5% 175.3% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.8% 26.1% 119.9% 78.3% -0.3% -1.9% 0.0% 0.0%   ROI %   118.0% 83.1% 216.5% 105.3% -0.3% -1.9% 0.0% 0.0%   ROE %   92.9% 66.5% 170.2% 90.1% -0.2% -1.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   29.7% 31.7% 60.6% 99.1% 100.0% 99.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -101.4% -80.4% -29.3% 2,760.9% 19,251.9% 5,131.4% 0.0% 0.0%   Gearing %   0.4% 5.1% 0.4% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   49.5% 0.0% 35.2% 109.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.7 2.5 112.7 0.0 134.0 0.0 0.0   Current Ratio   1.2 1.1 2.5 112.7 0.0 134.0 0.0 0.0   Cash and cash equivalent   559.3 414.1 1,233.0 1,025.5 1,005.1 1,000.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   222.8 88.8 3,287.1 1,921.9 13.0 -2.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0